These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3007307)

  • 1. Assessment of oxidative metabolism in adults with hepatocellular carcinoma in the Sudan.
    Homeida MM; Daneshmend TK; Ali EM; Yousif-Elkadaru AG; Arbab BM
    Gut; 1986 Apr; 27(4):382-5. PubMed ID: 3007307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine clearance per unit liver volume in cirrhotics with and without hepatocellular carcinoma indicating a correlation with histological change of the liver.
    Noda S; Kawata S; Miyoshi S; Minami Y; Tarui S
    Gastroenterol Jpn; 1989 Apr; 24(2):159-63. PubMed ID: 2545499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients.
    Grieco A; Castellano R; Matera A; Marcoccia S; Di Rocco P; Ragazzoni E; Vecchio FM; Gasbarrini G
    J Gastroenterol Hepatol; 1998 May; 13(5):460-6. PubMed ID: 9641640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in drug metabolizing ability: a study with antipyrine in the Sudan.
    Branch RA; Salih SY; Homeida M
    Clin Pharmacol Ther; 1978 Sep; 24(3):283-6. PubMed ID: 688721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    J Cancer Res Clin Oncol; 1987; 113(6):593-8. PubMed ID: 2824523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation.
    Tranvouez JL; Lerebours E; Chretien P; Fouin-Fortunet H; Colin R
    Am J Clin Nutr; 1985 Jun; 41(6):1257-64. PubMed ID: 3923817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine and lidocaine are cleared faster in horses than in humans: acetaminophen may be handled similarly.
    Engelking LR; Lofstedt J; Blyden GT; Greenblatt DJ
    Pharmacology; 1987; 34(4):192-200. PubMed ID: 3602088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine metabolism and bronchogenic carcinoma.
    Ambre J; Graeff D; Bures F; Haupt D; Deason K
    J Med; 1977; 8(1):57-70. PubMed ID: 267157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of mixed function oxidases, estimated by in vivo antipyrine clearance, is similar in horses and camels.
    Wasfi IA; Zorob OM; Boni NS; Hadi AA; Agha BA; Elghazali M
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Feb; 119(2):139-42. PubMed ID: 9669082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.
    Higuchi T; Nakamura T; Uchino H
    Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pesticide exposure on human microsomal enzyme induction.
    Uppal R; Sharma PR; Chaudhury RR
    Hum Toxicol; 1982 Mar; 1(2):155-8. PubMed ID: 7173896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training does not alter cytochrome P-450 content and microsomal metabolism.
    Michaud TJ; Bachmann KA; Andres FF; Flynn MG; Sherman GP; Rodriguez-Zayas J
    Med Sci Sports Exerc; 1994 Aug; 26(8):978-82. PubMed ID: 7968432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma antipyrine half-life and hepatic microsomal antipyrine hydroxylase activity in rabbits.
    Statland BE; Astrup P; Black CH; Oxholm E
    Pharmacology; 1973; 10(6):329-37. PubMed ID: 4784365
    [No Abstract]   [Full Text] [Related]  

  • 19. No impairment of antipyrine elimination by the selective anticholinergic drug pirenzepine.
    Paxton JW; Foote SE; Paton DM
    Digestion; 1983; 27(1):44-6. PubMed ID: 6688400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.